Summary
A prospective epidemiological study of the Neonatal Hepatitis Syndrome in S.E. England showed Alpha-1-Antitrypsin Deficiency (Pi ZZ) to be present in seven out of fifty-twopatients. Data are considered from these seven patients, and from a further six cases from outside this area. The nature of acute illness, pathological changes on early liver biopsy, and short-term prognosis show considerable variability, but in general the hepatitis is more severe in patients with Alpha-1-A.T. deficiency than in those in whom no aetiological factor was found.
THE following clinical features were observed in thirteen children who presented with the Neonatal Hepatitis Syndrome and a genetic deficiency of alpha-1-antitrypsin. The Indeed, of all the six infants that were tested from this group of nine, similar continuing abnormalities in liver function tests are detectable on follow-up study. Thus, in spite of their relative wellbeing, one is still unsure of the ultimate outcome of their condition.
The duration of follow-up of cases of Neonatal Hepatitis Syndrome in whom no aetiological factor was identified, i.e. the 'unclassified' group-is too short to comment on their ultimate outcome. Nevertheless, it is noteworthy that of forty-eight such cases observed so far, only six show evidence of fibrosis or cirrhosis on early liver biopsy, as opposed to eight out of the thirteen with alpha-1-antitrypsin deficiency. There has been only one death due to liver disease out of this 'unclassified' group. Thus the prognosis for patients with the Neonatal Hepatitis Syndrome and Pi ZZ phenotype does appear to be worse than for patients who have normal alpha-1-antitrypsin.
Conclusion
Our observations of the Neonatal Hepatitis Syndrome and alpha-1-antitrypsin deficiency, show that:
(1) in a circumscribed area that was studied the frequency of alpha-1-antitrypsin deficiency is similar to that of biliary atresia; (2) Dr Eddleston commented that some of the liver disease in children we were talking about was clearly caused by viral hepatitis but much of it was illdefined, but one had to adopt definitions which were workable, for example some of the children had already developed cirrhosis, some had jaundice which was due to hepatocellular disfunction, in others cholestasis appeared to be the predominant abnormality. If one were to use such terms one could make a start to classifying these conditions and defining groups of some homogeneity with uniform response to treatment X or Y. It was certainly not good enough to talk about hepatitis without characterizing the condition further.
